01
Neonatal Hyperbilirubinemia
Hemolytic jaundice, rapid bilirubin rise, oxidative stress phenotype, kernicterus prevention, phototherapy optimization.
Field record
Neonatal intensive care — the first of six populations under outcomes tracking.
Birth | Battlefield | Beyond
Every averted hemolytic crisis is another battle won!
A veteran-led clinical outcomes from the NICU incubator through battlefield medicine to veteran care.
Founded on a service-connected commitment to veterans, neonates, mothers, and populations at hemolytic risk worldwide.
Miami, FL · Veteran owned
Our Mission
Turning bedside practice into transferable evidence.
OxVet Registry is a veteran-founded clinical outcomes platform dedicated to identifying, validating, and scaling therapeutic interventions that improve patient outcomes across hemolytic crises, transplant optimization, and critical care emergencies.
We work with leading medical institutions, transplant centers, military medical facilities, and international partners to aggregate outcomes data, develop standardized protocols, and navigate regulatory pathways to bring evidence-based care to all populations — from neonatal and maternal medicine to wounded veterans and resource-limited international settings.
Transform institutional clinical innovations into reproducible, scalable outcomes that save lives.
OxVet Registry — statement of purposeWhere We Work
Six populations at risk of hemolytic crisis
Each cohort carries its own oxidative-stress phenotype, its own clock, and its own definition of a good outcome. The registry tracks all six on their own terms.
02
Maternal Hemolytic Crisis
Pregnancy and postpartum hemolysis, G6PD overlap, transfusion avoidance, fetal and neonatal outcomes optimization.
03
Transplant Perioperative Crisis
Kidney and liver transplant optimization, perioperative hemolysis, graft survival, rejection prevention, encephalopathy prevention.
04
Acute Hemolytic Episode
Rapid hemoglobin decline, oxidative stress emergency, transfusion avoidance, ICU optimization, rapid recovery.
05
Endemic Malaria Zones
G6PD-malaria overlap, 400M+ at-risk population, severe anemia prevention, mortality reduction, resource-limited settings.
06
Battle Theater Medicine
Forward-deployed personnel, malaria-endemic theaters, hemolytic crisis prevention, medevac avoidance, operational readiness.
The Evidence Standard
We publish what we measure — not what we hope
OxVet does not market outcomes it has not earned. Below are the endpoints under active tracking and the method by which practice becomes evidence.
400M+
At-risk population in G6PD-malaria overlap zones
6
Populations under active outcomes tracking
Zero
Cost to participating institutions
Tracked endpoints by domain
Neonatal
Bilirubin trajectory
Kernicterus prevention
Phototherapy duration
Maternal
Transfusion avoidance
Postpartum hemolysis
Fetal outcomes
Transplant
Graft survival
Rejection prevention
Encephalopathy prevention
Acute care
Hemoglobin decline
ICU length of stay
Time to recovery
Global health
Severe anemia prevention
Mortality reduction
G6PD-malaria overlap
Operational
Medevac avoidance
Crisis prevention
Operational readiness
How the registry works
-
Aggregate
Cross-reference outcomes data collected across partner institutions and historical records to gain insights that are actionable.
-
Standardize
Reproducible protocols developed from aggregated practice, so a result in one unit transfers to the next.
-
Navigate
Regulatory pathways mapped to move validated protocols toward broad, evidence-based adoption.
Why OxVet
01
Evidence-Based Outcomes
We track outcomes across institutions pioneering care and promote extensions that advance treatment effective protocols.
02
Institutional Partnership
Zero cost to your institution. We integrate with existing protocols, turning your current practice into outcomes evidence.
03
Veteran Mission
Founded on service-connected commitment to advancing care for veterans, neonates, mothers, and international populations at hemolytic risk.
Partnerships
Four categories of institutional partner
The registry integrates with protocols already in use. There is no cost to a participating institution and no new system to adopt — existing practice becomes the evidence base.
Discuss a partnership →01
Neonatal HIE Programs
Academic NICUs and neonatal encephalopathy programs contributing outcomes data.
02
Transplant Centers
Kidney and liver transplant services tracking perioperative outcomes and graft survival.
03
Military & VA
Veterans Affairs medical centers and military treatment facilities across acute and deployed care.
04
International
Global health bodies and foundations working in malaria-endemic, resource-limited settings.
Get In Touch
Partnership inquiry
Tell us about your institution and the population you treat. We read every inquiry ourselves.
We follow up within 48 hours.